chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Dysarthria, Ear pain, Facial paralysis, Headache
Clinical narrative: Drooping face; Bell's palsy; face numbness sensation, increasing daily; Headache; pain behind and in front right ear; Slurred speech; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 17:30 (Lot number: 301358A) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). Concomitant medication(s) included: VALSARTAN; HYDROCHLOROTHIAZIDE; OMEPRAZOLE. The following information was reported: FACIAL PARALYSIS (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "Drooping face"; BELL'S PALSY (hospitalization, disability, medically significant) with onset 13Oct2021 18:00, outcome "recovering", described as "Bell's palsy"; HYPOAESTHESIA (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "face numbness sensation, increasing daily"; HEADACHE (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "Headache"; EAR PAIN (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "pain behind and in front right ear"; DYSARTHRIA (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "Slurred speech". The patient was hospitalized for facial paralysis, bell's palsy, hypoaesthesia, headache, ear pain, dysarthria (hospitalization duration: 2 day(s)). The events "drooping face", "bell's palsy", "face numbness sensation, increasing daily", "headache", "pain behind and in front right ear" and "slurred speech" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (13Oct2021) negative, notes: Nasal swab. Therapeutic measures were taken as a result of facial paralysis, bell's palsy, hypoaesthesia, headache, ear pain, dysarthria. Additional information: the patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient has not been diagnosed with COVID-19. Patient did not have known allergies.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: Drooping face; Bell's palsy; face numbness sensation, increasing daily; Headache; pain behind and in front right ear; Slurred speech; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 17:30 (Lot number: 301358A) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). Concomitant medication(s) included: VALSARTAN; HYDROCHLOROTHIAZIDE; OMEPRAZOLE. The following information was reported: FACIAL PARALYSIS (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "Drooping face"; BELL'S PALSY (hospitalization, disability, medically significant) with onset 13Oct2021 18:00, outcome "recovering", described as "Bell's palsy"; HYPOAESTHESIA (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "face numbness sensation, increasing daily"; HEADACHE (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "Headache"; EAR PAIN (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "pain behind and in front right ear"; DYSARTHRIA (hospitalization, disability) with onset 13Oct2021 18:00, outcome "recovering", described as "Slurred speech". The patient was hospitalized for facial paralysis, bell's palsy, hypoaesthesia, headache, ear pain, dysarthria (hospitalization duration: 2 day(s)). The events "drooping face", "bell's palsy", "face numbness sensation, increasing daily", "headache", "pain behind and in front right ear" and "slurred speech" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (13Oct2021) negative, notes: Nasal swab. Therapeutic measures were taken as a result of facial paralysis, bell's palsy, hypoaesthesia, headache, ear pain, dysarthria. Additional information: the patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient has not been diagnosed with COVID-19. Patient did not have known allergies.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: bad metallic taste; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 36 year-old female patient received BNT162b2 (BNT162B2), administered in arm right, administration date 26Mar2021 14:00 (Lot number: EP6955) at the age of 36 years as dose 1, single and administered in arm right, administration date 16Apr2021 (Lot number: 6W0161) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Hashimoto's disease" (unspecified if ongoing); "Overactive bladder" (unspecified if ongoing); "permanent nerve damage" (unspecified if ongoing); "C5C6 plates and screws" (unspecified if ongoing); "concussion", start date: 2015 (unspecified if ongoing); "hurt at work with a concussion", start date: 2015 (unspecified if ongoing), notes: hurt at work with a concussion; "post concussion syndrome", start date: 2015 (unspecified if ongoing), notes: for 16 months; "permanent damage with the right arm", start date: 2015 (unspecified if ongoing), notes: This injury was in 2015; "Muscle spasms" (unspecified if ongoing); "migraines" (unspecified if ongoing); "chronic pain" (unspecified if ongoing); "swine flu" (unspecified if ongoing). Concomitant medication(s) included: LAMICTAL; SYNTHROID; LYRICA taken for nerve injury; TRAMADOL; VALIUM taken for muscle spasms. Past drug history included: Bupivacaine, notes: having the bupivacaine injections for years and has never had a problem with them; Reglan, reaction(s): "Known allergies: reglan"; Compazine, reaction(s): "Known allergies: compazine". The following information was reported: DYSGEUSIA (non-serious), outcome "unknown", described as "bad metallic taste". Additional information: The patient had a bad metallic taste after the first two doses of the Pfizer covid vaccine but other than that she was fine. The lot number of dose 2 was also reported as EW0161.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test, Vaccination failure, Wheezing
Clinical narrative: heart failure; The initial case was missing the following minimum criteria: unspecified product. Upon receipt of follow-up information on 07Feb2022, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter (Consumer) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC FAILURE (medically significant) with onset 2021, outcome "unknown", described as "heart failure". The patient underwent the following laboratory tests and procedures: doing so many tests with unknown result. Additional information: The patient reported that after Pfizer COVID-19 vaccine, she had heart failure at the beginning of the year (2021). She mentioned that she was not able to send the paperwork right away is because she has been busy going to the doctors and doing so many tests. Her doctor has told her she is lucky to be alive and that she has heart failure for the rest of her life. She said she cannot take the booster because of the adverse event.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: X-ray
Clinical narrative: heart failure; The initial case was missing the following minimum criteria: unspecified product. Upon receipt of follow-up information on 07Feb2022, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter (Consumer) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC FAILURE (medically significant) with onset 2021, outcome "unknown", described as "heart failure". The patient underwent the following laboratory tests and procedures: doing so many tests with unknown result. Additional information: The patient reported that after Pfizer COVID-19 vaccine, she had heart failure at the beginning of the year (2021). She mentioned that she was not able to send the paperwork right away is because she has been busy going to the doctors and doing so many tests. Her doctor has told her she is lucky to be alive and that she has heart failure for the rest of her life. She said she cannot take the booster because of the adverse event.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac failure, Investigation
Clinical narrative: heart failure; The initial case was missing the following minimum criteria: unspecified product. Upon receipt of follow-up information on 07Feb2022, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter (Consumer) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC FAILURE (medically significant) with onset 2021, outcome "unknown", described as "heart failure". The patient underwent the following laboratory tests and procedures: doing so many tests with unknown result. Additional information: The patient reported that after Pfizer COVID-19 vaccine, she had heart failure at the beginning of the year (2021). She mentioned that she was not able to send the paperwork right away is because she has been busy going to the doctors and doing so many tests. Her doctor has told her she is lucky to be alive and that she has heart failure for the rest of her life. She said she cannot take the booster because of the adverse event.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Bradycardia, Cerebrovascular accident, Computerised tomogram, Magnetic resonance imaging
Clinical narrative: STROKE; BRADYCARDIA; FELT SOME CONFUSION; FORGETFULNESS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: occasional alcohol use, non-smoker, and hypertension. The patient did not have history of drug abuse or illicit drug use and had no known drug allergies. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported and batch number: 202A21A and expiry date: unknown) dose was not reported, 1 total, administered on 10-APR-2021 to right arm for prophylactic vaccination. On 11-APR-2021, the patient stated that he experienced sore arm from the initial Johnson and Johnson Covid-19 vaccine and stated which was resolved on 12-APR-2021 (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry date: unknown) dose was not reported, 1 total, administered on 12-DEC-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 13-DEC-2021, the patient felt some confusion and forgetfulness after the booster dose (Dose number in series 2). It was resolved on 14-DEC-2021. On 22-DEC-2021, the patient experienced stroke and his wife called emergency and he went to the medical facility. When stroke happened, he also experienced Vertigo, vomiting, and tiredness/fatigue, which the tiredness he attributed to the bradycardia he experienced (Dose number in series 2). The patient's heart rate went down to 20 bpm (beats per minute) and it was treated with atropine by the caregivers. The patient went to the hospital on 22-DEC-2021, and was treated with TPA (Tissue plasminogen activator) and was discharged from hospital on 24-DEC-2021 (Dose number in series 2). Upon discharge, he could not walk for two weeks due to dizziness/vertigo. The patient was still doing physical therapy for the vertigo symptoms as on report time. The patient would see the physician again on 02-FEB-2022.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bradycardia on 29-DEC-2021, and felt some confusion, and forgetfulness on 14-DEC-2021, and was recovering from stroke. This report was serious (Hospitalization Caused / Prolonged). This case, involving the same patient is linked to 20220200341 (Dose number in series 1).; Sender's Comments: V0: 20220210630-covid-19 vaccine ad26.cov2.s- bradycardia,  stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: STROKE; BRADYCARDIA; FELT SOME CONFUSION; FORGETFULNESS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: occasional alcohol use, non-smoker, and hypertension. The patient did not have history of drug abuse or illicit drug use and had no known drug allergies. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported and batch number: 202A21A and expiry date: unknown) dose was not reported, 1 total, administered on 10-APR-2021 to right arm for prophylactic vaccination. On 11-APR-2021, the patient stated that he experienced sore arm from the initial Johnson and Johnson Covid-19 vaccine and stated which was resolved on 12-APR-2021 (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry date: unknown) dose was not reported, 1 total, administered on 12-DEC-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 13-DEC-2021, the patient felt some confusion and forgetfulness after the booster dose (Dose number in series 2). It was resolved on 14-DEC-2021. On 22-DEC-2021, the patient experienced stroke and his wife called emergency and he went to the medical facility. When stroke happened, he also experienced Vertigo, vomiting, and tiredness/fatigue, which the tiredness he attributed to the bradycardia he experienced (Dose number in series 2). The patient's heart rate went down to 20 bpm (beats per minute) and it was treated with atropine by the caregivers. The patient went to the hospital on 22-DEC-2021, and was treated with TPA (Tissue plasminogen activator) and was discharged from hospital on 24-DEC-2021 (Dose number in series 2). Upon discharge, he could not walk for two weeks due to dizziness/vertigo. The patient was still doing physical therapy for the vertigo symptoms as on report time. The patient would see the physician again on 02-FEB-2022.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bradycardia on 29-DEC-2021, and felt some confusion, and forgetfulness on 14-DEC-2021, and was recovering from stroke. This report was serious (Hospitalization Caused / Prolonged). This case, involving the same patient is linked to 20220200341 (Dose number in series 1).; Sender's Comments: V0: 20220210630-covid-19 vaccine ad26.cov2.s- bradycardia,  stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bradycardia, Cerebrovascular accident, Confusional state, Heart rate, Memory impairment
Clinical narrative: STROKE; BRADYCARDIA; FELT SOME CONFUSION; FORGETFULNESS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: occasional alcohol use, non-smoker, and hypertension. The patient did not have history of drug abuse or illicit drug use and had no known drug allergies. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported and batch number: 202A21A and expiry date: unknown) dose was not reported, 1 total, administered on 10-APR-2021 to right arm for prophylactic vaccination. On 11-APR-2021, the patient stated that he experienced sore arm from the initial Johnson and Johnson Covid-19 vaccine and stated which was resolved on 12-APR-2021 (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry date: unknown) dose was not reported, 1 total, administered on 12-DEC-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 13-DEC-2021, the patient felt some confusion and forgetfulness after the booster dose (Dose number in series 2). It was resolved on 14-DEC-2021. On 22-DEC-2021, the patient experienced stroke and his wife called emergency and he went to the medical facility. When stroke happened, he also experienced Vertigo, vomiting, and tiredness/fatigue, which the tiredness he attributed to the bradycardia he experienced (Dose number in series 2). The patient's heart rate went down to 20 bpm (beats per minute) and it was treated with atropine by the caregivers. The patient went to the hospital on 22-DEC-2021, and was treated with TPA (Tissue plasminogen activator) and was discharged from hospital on 24-DEC-2021 (Dose number in series 2). Upon discharge, he could not walk for two weeks due to dizziness/vertigo. The patient was still doing physical therapy for the vertigo symptoms as on report time. The patient would see the physician again on 02-FEB-2022.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bradycardia on 29-DEC-2021, and felt some confusion, and forgetfulness on 14-DEC-2021, and was recovering from stroke. This report was serious (Hospitalization Caused / Prolonged). This case, involving the same patient is linked to 20220200341 (Dose number in series 1).; Sender's Comments: V0: 20220210630-covid-19 vaccine ad26.cov2.s- bradycardia,  stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Anxiety, Arthralgia, Aspiration, Colonoscopy normal
Clinical narrative: Lower abdominal cramping; Left arm pain; Pain in upper shoulders; the pain messing with lymph under her underarm pit; pain in upper shoulders in muscle; arm felt heavy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 19Apr2021, outcome "recovered", described as "Left arm pain"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Pain in upper shoulders"; ABDOMINAL PAIN LOWER (non-serious) with onset 26Jun2021, outcome "unknown", described as "Lower abdominal cramping"; LYMPH NODE PAIN (non-serious) with onset 2021, outcome "recovered", described as "the pain messing with lymph under her underarm pit"; MYALGIA (non-serious) with onset 2021, outcome "not recovered", described as "pain in upper shoulders in muscle"; LIMB DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "arm felt heavy". The event "lower abdominal cramping" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of abdominal pain lower.  Additional Information: The first thing she experienced was after she got the 2nd vaccine, her left arm was hurting and felt the pain messing with lymph under her underarm pit.  It lasted for a couple of days and it went away. Then she had pain in upper shoulders in muscle.  She would lay on her side and would still have pain and did not think anything, thinking she slept on it wrong.  It has gotten worse.  The arm felt heavy and was messing with lymph under arm pit.  The pain in shoulders started a week later. Then, 8 weeks later, she began having lower abdominal cramping.  She kept going to the ER and no one knew what was wrong.  She went to ER and was treated and released the first time on 26Jun2021.  She said she would try to catch her breath.  Unable to confirm the remainder of statement as caller placed call handler on hold and never came back.  Unable to confirm outcome of lower abdominal cramping.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depression, Diarrhoea, Diplopia, Hysterectomy, Malaise
Clinical narrative: Lower abdominal cramping; Left arm pain; Pain in upper shoulders; the pain messing with lymph under her underarm pit; pain in upper shoulders in muscle; arm felt heavy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 19Apr2021, outcome "recovered", described as "Left arm pain"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Pain in upper shoulders"; ABDOMINAL PAIN LOWER (non-serious) with onset 26Jun2021, outcome "unknown", described as "Lower abdominal cramping"; LYMPH NODE PAIN (non-serious) with onset 2021, outcome "recovered", described as "the pain messing with lymph under her underarm pit"; MYALGIA (non-serious) with onset 2021, outcome "not recovered", described as "pain in upper shoulders in muscle"; LIMB DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "arm felt heavy". The event "lower abdominal cramping" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of abdominal pain lower.  Additional Information: The first thing she experienced was after she got the 2nd vaccine, her left arm was hurting and felt the pain messing with lymph under her underarm pit.  It lasted for a couple of days and it went away. Then she had pain in upper shoulders in muscle.  She would lay on her side and would still have pain and did not think anything, thinking she slept on it wrong.  It has gotten worse.  The arm felt heavy and was messing with lymph under arm pit.  The pain in shoulders started a week later. Then, 8 weeks later, she began having lower abdominal cramping.  She kept going to the ER and no one knew what was wrong.  She went to ER and was treated and released the first time on 26Jun2021.  She said she would try to catch her breath.  Unable to confirm the remainder of statement as caller placed call handler on hold and never came back.  Unable to confirm outcome of lower abdominal cramping.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Oropharyngeal pain, Suicidal ideation, Uterine inflammation
Clinical narrative: Lower abdominal cramping; Left arm pain; Pain in upper shoulders; the pain messing with lymph under her underarm pit; pain in upper shoulders in muscle; arm felt heavy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 19Apr2021, outcome "recovered", described as "Left arm pain"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Pain in upper shoulders"; ABDOMINAL PAIN LOWER (non-serious) with onset 26Jun2021, outcome "unknown", described as "Lower abdominal cramping"; LYMPH NODE PAIN (non-serious) with onset 2021, outcome "recovered", described as "the pain messing with lymph under her underarm pit"; MYALGIA (non-serious) with onset 2021, outcome "not recovered", described as "pain in upper shoulders in muscle"; LIMB DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "arm felt heavy". The event "lower abdominal cramping" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of abdominal pain lower.  Additional Information: The first thing she experienced was after she got the 2nd vaccine, her left arm was hurting and felt the pain messing with lymph under her underarm pit.  It lasted for a couple of days and it went away. Then she had pain in upper shoulders in muscle.  She would lay on her side and would still have pain and did not think anything, thinking she slept on it wrong.  It has gotten worse.  The arm felt heavy and was messing with lymph under arm pit.  The pain in shoulders started a week later. Then, 8 weeks later, she began having lower abdominal cramping.  She kept going to the ER and no one knew what was wrong.  She went to ER and was treated and released the first time on 26Jun2021.  She said she would try to catch her breath.  Unable to confirm the remainder of statement as caller placed call handler on hold and never came back.  Unable to confirm outcome of lower abdominal cramping.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain lower, Arthralgia, Limb discomfort, Lymph node pain, Myalgia
Clinical narrative: Lower abdominal cramping; Left arm pain; Pain in upper shoulders; the pain messing with lymph under her underarm pit; pain in upper shoulders in muscle; arm felt heavy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 19Apr2021, outcome "recovered", described as "Left arm pain"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Pain in upper shoulders"; ABDOMINAL PAIN LOWER (non-serious) with onset 26Jun2021, outcome "unknown", described as "Lower abdominal cramping"; LYMPH NODE PAIN (non-serious) with onset 2021, outcome "recovered", described as "the pain messing with lymph under her underarm pit"; MYALGIA (non-serious) with onset 2021, outcome "not recovered", described as "pain in upper shoulders in muscle"; LIMB DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "arm felt heavy". The event "lower abdominal cramping" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of abdominal pain lower.  Additional Information: The first thing she experienced was after she got the 2nd vaccine, her left arm was hurting and felt the pain messing with lymph under her underarm pit.  It lasted for a couple of days and it went away. Then she had pain in upper shoulders in muscle.  She would lay on her side and would still have pain and did not think anything, thinking she slept on it wrong.  It has gotten worse.  The arm felt heavy and was messing with lymph under arm pit.  The pain in shoulders started a week later. Then, 8 weeks later, she began having lower abdominal cramping.  She kept going to the ER and no one knew what was wrong.  She went to ER and was treated and released the first time on 26Jun2021.  She said she would try to catch her breath.  Unable to confirm the remainder of statement as caller placed call handler on hold and never came back.  Unable to confirm outcome of lower abdominal cramping.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Lower abdominal cramping; Left arm pain; Pain in upper shoulders; the pain messing with lymph under her underarm pit; pain in upper shoulders in muscle; arm felt heavy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 19Apr2021, outcome "recovered", described as "Left arm pain"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Pain in upper shoulders"; ABDOMINAL PAIN LOWER (non-serious) with onset 26Jun2021, outcome "unknown", described as "Lower abdominal cramping"; LYMPH NODE PAIN (non-serious) with onset 2021, outcome "recovered", described as "the pain messing with lymph under her underarm pit"; MYALGIA (non-serious) with onset 2021, outcome "not recovered", described as "pain in upper shoulders in muscle"; LIMB DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "arm felt heavy". The event "lower abdominal cramping" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of abdominal pain lower.  Additional Information: The first thing she experienced was after she got the 2nd vaccine, her left arm was hurting and felt the pain messing with lymph under her underarm pit.  It lasted for a couple of days and it went away. Then she had pain in upper shoulders in muscle.  She would lay on her side and would still have pain and did not think anything, thinking she slept on it wrong.  It has gotten worse.  The arm felt heavy and was messing with lymph under arm pit.  The pain in shoulders started a week later. Then, 8 weeks later, she began having lower abdominal cramping.  She kept going to the ER and no one knew what was wrong.  She went to ER and was treated and released the first time on 26Jun2021.  She said she would try to catch her breath.  Unable to confirm the remainder of statement as caller placed call handler on hold and never came back.  Unable to confirm outcome of lower abdominal cramping.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Fatigue
Clinical narrative: dizzy; slept all night; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 10Mar2021, outcome "unknown", described as "dizzy"; SLEEP DISORDER (non-serious) with onset 10Mar2021, outcome "unknown", described as "slept all night"; FATIGUE (non-serious) with onset 10Mar2021, outcome "unknown", described as "tired".  Additional Information: Patient reported that she received her first dose on the previous day and felt dizzy, slept all night because she felt tired.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Sleep disorder
Clinical narrative: dizzy; slept all night; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 10Mar2021, outcome "unknown", described as "dizzy"; SLEEP DISORDER (non-serious) with onset 10Mar2021, outcome "unknown", described as "slept all night"; FATIGUE (non-serious) with onset 10Mar2021, outcome "unknown", described as "tired".  Additional Information: Patient reported that she received her first dose on the previous day and felt dizzy, slept all night because she felt tired.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Pericarditis
Clinical narrative: Saw Cardiologist after receiving second dose Pfizer Covid Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1,MANUFACTURER UNKNOWN), for covid-19 immunization. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Saw Cardiologist after receiving second dose Pfizer Covid Vaccine". The event "saw cardiologist after receiving second dose pfizer covid vaccine" was evaluated at the physician office visit.  Additional Information: The patient received the second dose Pfizer Covid Vaccine and had a horrible reaction. The patient ended up in the hospital and had marcaditis and paraditis. The patient clarifies the was transported via ambulance to the emergency room and was in the emergency room for 6 or 7 hours until sorted out.Saw Cardiologist after receiving second dose Pfizer Covid Vaccine: When saw the cardiologist, the cardiologist said the patient was like the third person the cardiologist had seen. The three persons were young men, all seeing the cardiologist after receiving second dose Pfizer Covid Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac disorder
Clinical narrative: Saw Cardiologist after receiving second dose Pfizer Covid Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1,MANUFACTURER UNKNOWN), for covid-19 immunization. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Saw Cardiologist after receiving second dose Pfizer Covid Vaccine". The event "saw cardiologist after receiving second dose pfizer covid vaccine" was evaluated at the physician office visit.  Additional Information: The patient received the second dose Pfizer Covid Vaccine and had a horrible reaction. The patient ended up in the hospital and had marcaditis and paraditis. The patient clarifies the was transported via ambulance to the emergency room and was in the emergency room for 6 or 7 hours until sorted out.Saw Cardiologist after receiving second dose Pfizer Covid Vaccine: When saw the cardiologist, the cardiologist said the patient was like the third person the cardiologist had seen. The three persons were young men, all seeing the cardiologist after receiving second dose Pfizer Covid Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Pericarditis
Clinical narrative: Saw Cardiologist after receiving second dose Pfizer Covid Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 Immunization.  The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Saw Cardiologist after receiving second dose Pfizer Covid Vaccine".  Additional information: Patient reported that he received the second dose Pfizer Covid Vaccine and had myocarditis and pericarditis. When the patient saw the cardiologist, the cardiologist said that the patient was like the third person the cardiologist had seen. All the young men were seeing the cardiologist after receiving second dose Pfizer Covid Vaccine. The young men were between ages 27 and 35.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac disorder
Clinical narrative: Saw Cardiologist after receiving second dose Pfizer Covid Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 Immunization.  The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Saw Cardiologist after receiving second dose Pfizer Covid Vaccine".  Additional information: Patient reported that he received the second dose Pfizer Covid Vaccine and had myocarditis and pericarditis. When the patient saw the cardiologist, the cardiologist said that the patient was like the third person the cardiologist had seen. All the young men were seeing the cardiologist after receiving second dose Pfizer Covid Vaccine. The young men were between ages 27 and 35.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Vision blurred
Clinical narrative: His legs felt really heavy above his ankles, in the evening the heaviness did go away; His vision became blurry; His arm was sore and it's still sore and red at the injection site; His arm was sore and it's still sore and red at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jan2022 10:15 (Lot number: FF2589) at the age of 17 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st), for COVID-19 immunization, reaction(s): "they were just tired the next day"; Bnt162b2 (Dose: 2nd), for COVID-19 immunization. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 14Jan2022 11:15, outcome "recovered" (14Jan2022), described as "His legs felt really heavy above his ankles, in the evening the heaviness did go away"; VISION BLURRED (non-serious) with onset 14Jan2022 10:35, outcome "recovered" (Jan2022), described as "His vision became blurry"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 14Jan2022, outcome "not recovered" and all described as "His arm was sore and it's still sore and red at the injection site". Therapeutic measures were not taken as a result of limb discomfort, vision blurred, vaccination site pain, vaccination site erythema. No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Vaccination site erythema, Vaccination site pain, Vision blurred
Clinical narrative: His legs felt really heavy above his ankles, in the evening the heaviness did go away; His vision became blurry; His arm was sore and it's still sore and red at the injection site; His arm was sore and it's still sore and red at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jan2022 10:15 (Lot number: FF2589) at the age of 17 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st), for COVID-19 immunization, reaction(s): "they were just tired the next day"; Bnt162b2 (Dose: 2nd), for COVID-19 immunization. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 14Jan2022 11:15, outcome "recovered" (14Jan2022), described as "His legs felt really heavy above his ankles, in the evening the heaviness did go away"; VISION BLURRED (non-serious) with onset 14Jan2022 10:35, outcome "recovered" (Jan2022), described as "His vision became blurry"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 14Jan2022, outcome "not recovered" and all described as "His arm was sore and it's still sore and red at the injection site". Therapeutic measures were not taken as a result of limb discomfort, vision blurred, vaccination site pain, vaccination site erythema. No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Pain in extremity, Vaccination site erythema, Vision blurred
Clinical narrative: His legs felt really heavy above his ankles, in the evening the heaviness did go away; His vision became blurry; His arm was sore and it's still sore and red at the injection site; His arm was sore and it's still sore and red at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jan2022 10:15 (Lot number: FF2589) at the age of 17 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st), for COVID-19 immunization, reaction(s): "they were just tired the next day"; Bnt162b2 (Dose: 2nd), for COVID-19 immunization. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 14Jan2022 11:15, outcome "recovered" (14Jan2022), described as "His legs felt really heavy above his ankles, in the evening the heaviness did go away"; VISION BLURRED (non-serious) with onset 14Jan2022 10:35, outcome "recovered" (Jan2022), described as "His vision became blurry"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 14Jan2022, outcome "not recovered" and all described as "His arm was sore and it's still sore and red at the injection site". Therapeutic measures were not taken as a result of limb discomfort, vision blurred, vaccination site pain, vaccination site erythema. No follow-up attempts are possible. No further information is expected.